The US Food and Drug Administration (FDA) is soliciting input on how it might accelerate the development of certain drug products through the use of new and emerging biomarkers. In FDA's ...
FDA moves shaping drug development and oversight include new gene therapy guidance, clinical trial transparency efforts, and recent drug approvals.
As discussed previously (“New FDA Guidance Allows Biosimilar Applicants to Use Data From Outside the U.S. To Accelerate Their Approval in the ...
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18 executive order calling to speed up access to ...
It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use ...
The Food and Drug Administration is a government agency that regulates certain food, drugs, cosmetics, and medical products.
Twelve months after releasing a roadmap to shift away from animal testing requirements, the FDA has declared mission ...